Cargando…

Electronic Portal Imaging Device-Based Three-Dimensional Volumetric Dosimetry for Intensity-modulated Radiotherapy Pretreatment Quality Assurance

AIM: This study aimed at evaluating the efficacy of treatment planning system (TPS)-based heterogeneity correction for two- and three-dimensional (2D and 3D) electronic portal imaging device (EPID)-based pretreatment dose verification. An experiment was conducted on the EPID back-projection techniqu...

Descripción completa

Detalles Bibliográficos
Autores principales: Arjunan, Manikandan, Sekaran, Sureka Chandra, Sarkar, Biplab, Manavalan, Saran Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764179/
https://www.ncbi.nlm.nih.gov/pubmed/31576065
http://dx.doi.org/10.4103/jmp.JMP_42_19
_version_ 1783454324604534784
author Arjunan, Manikandan
Sekaran, Sureka Chandra
Sarkar, Biplab
Manavalan, Saran Kumar
author_facet Arjunan, Manikandan
Sekaran, Sureka Chandra
Sarkar, Biplab
Manavalan, Saran Kumar
author_sort Arjunan, Manikandan
collection PubMed
description AIM: This study aimed at evaluating the efficacy of treatment planning system (TPS)-based heterogeneity correction for two- and three-dimensional (2D and 3D) electronic portal imaging device (EPID)-based pretreatment dose verification. An experiment was conducted on the EPID back-projection technique and intensity-modulated radiotherapy (IMRT). MATERIALS AND METHODS: Treatment plans were delivered in EPID without a patient to obtain the fluence pattern (F(EPID)). A heterogeneity correction plane (F(het)) for an open beam of 30 cm × 30 cm was extracted from the TPS. The heterogeneity-corrected measured fluence is developed by matrix element multiplication (F(Resultant) = F(EPID) × F(het)). Further planes were summed to develop a 3D dose distribution and exported to the TPS. Dose verifications for 2D and 3D were carried out with the corresponding TPS values using 2D gamma analysis (ɣ) and dose volume histogram (DVH) comparison, respectively. Totally, 33 patients (17 head–neck and 16 thorax cases) were evaluated in this study. RESULTS: The head–neck and thorax plans show a 3-mm-distance to agreement (DTA) 3% DD gamma passing of 96.3% ± 2.0% and 95.4% ± 1.8% points, respectively, between F(TPS) and F(Resultant). The comparison of the uncorrected measured fluence (F(EPID)) with F(TPS) reveals a gamma passing of 82.2% ± 7.3% and 80.4% ± 8.6% for head–neck and thorax cases, respectively. A total of 87 out of the 102 head–neck and thorax beams exhibit a planner gamma passing of 97.6% ± 2.1%. In the 3D-DVH comparison of thorax and head–neck cases, D5% for planning target volume were −0.5% ± 2.2% and −2.1% ± 3.5%, respectively; D95% varies as 1.0% ± 2.7% and 1.4% ± 1.1% between TPS calculated and heterogeneity-corrected-EPID-based dose reconstruction. CONCLUSION: The novel TPS-based heterogeneity correction can improve the 2D and 3D EPID-based back projection technique. Structures with large heterogeneities can also be handled using the proposed technique.
format Online
Article
Text
id pubmed-6764179
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-67641792019-10-01 Electronic Portal Imaging Device-Based Three-Dimensional Volumetric Dosimetry for Intensity-modulated Radiotherapy Pretreatment Quality Assurance Arjunan, Manikandan Sekaran, Sureka Chandra Sarkar, Biplab Manavalan, Saran Kumar J Med Phys Original Article AIM: This study aimed at evaluating the efficacy of treatment planning system (TPS)-based heterogeneity correction for two- and three-dimensional (2D and 3D) electronic portal imaging device (EPID)-based pretreatment dose verification. An experiment was conducted on the EPID back-projection technique and intensity-modulated radiotherapy (IMRT). MATERIALS AND METHODS: Treatment plans were delivered in EPID without a patient to obtain the fluence pattern (F(EPID)). A heterogeneity correction plane (F(het)) for an open beam of 30 cm × 30 cm was extracted from the TPS. The heterogeneity-corrected measured fluence is developed by matrix element multiplication (F(Resultant) = F(EPID) × F(het)). Further planes were summed to develop a 3D dose distribution and exported to the TPS. Dose verifications for 2D and 3D were carried out with the corresponding TPS values using 2D gamma analysis (ɣ) and dose volume histogram (DVH) comparison, respectively. Totally, 33 patients (17 head–neck and 16 thorax cases) were evaluated in this study. RESULTS: The head–neck and thorax plans show a 3-mm-distance to agreement (DTA) 3% DD gamma passing of 96.3% ± 2.0% and 95.4% ± 1.8% points, respectively, between F(TPS) and F(Resultant). The comparison of the uncorrected measured fluence (F(EPID)) with F(TPS) reveals a gamma passing of 82.2% ± 7.3% and 80.4% ± 8.6% for head–neck and thorax cases, respectively. A total of 87 out of the 102 head–neck and thorax beams exhibit a planner gamma passing of 97.6% ± 2.1%. In the 3D-DVH comparison of thorax and head–neck cases, D5% for planning target volume were −0.5% ± 2.2% and −2.1% ± 3.5%, respectively; D95% varies as 1.0% ± 2.7% and 1.4% ± 1.1% between TPS calculated and heterogeneity-corrected-EPID-based dose reconstruction. CONCLUSION: The novel TPS-based heterogeneity correction can improve the 2D and 3D EPID-based back projection technique. Structures with large heterogeneities can also be handled using the proposed technique. Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6764179/ /pubmed/31576065 http://dx.doi.org/10.4103/jmp.JMP_42_19 Text en Copyright: © 2019 Journal of Medical Physics http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Arjunan, Manikandan
Sekaran, Sureka Chandra
Sarkar, Biplab
Manavalan, Saran Kumar
Electronic Portal Imaging Device-Based Three-Dimensional Volumetric Dosimetry for Intensity-modulated Radiotherapy Pretreatment Quality Assurance
title Electronic Portal Imaging Device-Based Three-Dimensional Volumetric Dosimetry for Intensity-modulated Radiotherapy Pretreatment Quality Assurance
title_full Electronic Portal Imaging Device-Based Three-Dimensional Volumetric Dosimetry for Intensity-modulated Radiotherapy Pretreatment Quality Assurance
title_fullStr Electronic Portal Imaging Device-Based Three-Dimensional Volumetric Dosimetry for Intensity-modulated Radiotherapy Pretreatment Quality Assurance
title_full_unstemmed Electronic Portal Imaging Device-Based Three-Dimensional Volumetric Dosimetry for Intensity-modulated Radiotherapy Pretreatment Quality Assurance
title_short Electronic Portal Imaging Device-Based Three-Dimensional Volumetric Dosimetry for Intensity-modulated Radiotherapy Pretreatment Quality Assurance
title_sort electronic portal imaging device-based three-dimensional volumetric dosimetry for intensity-modulated radiotherapy pretreatment quality assurance
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764179/
https://www.ncbi.nlm.nih.gov/pubmed/31576065
http://dx.doi.org/10.4103/jmp.JMP_42_19
work_keys_str_mv AT arjunanmanikandan electronicportalimagingdevicebasedthreedimensionalvolumetricdosimetryforintensitymodulatedradiotherapypretreatmentqualityassurance
AT sekaransurekachandra electronicportalimagingdevicebasedthreedimensionalvolumetricdosimetryforintensitymodulatedradiotherapypretreatmentqualityassurance
AT sarkarbiplab electronicportalimagingdevicebasedthreedimensionalvolumetricdosimetryforintensitymodulatedradiotherapypretreatmentqualityassurance
AT manavalansarankumar electronicportalimagingdevicebasedthreedimensionalvolumetricdosimetryforintensitymodulatedradiotherapypretreatmentqualityassurance